RSM-932A (TCD-717) is a specific ChoKalpha inhibitor with IC50s of 1 and 33 µM for human recombinant ChoKalpha and ChoKbeta enzymes, respectively. RSM-932A acts as the ''first in humans compound targeting ChoKalpha. RSM-932A is potent in vitro anti-proliferative and in vivo anti-tumoral activity against human xenografts in mice, showing high efficacy with low toxicity profiles[1][2][3].
Molecular Weight:
877.53
Purity:
98.44
CAS Number:
[850807-63-5]
Formula:
C46H38Br2Cl2N4
Target:
Choline Kinase
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted